Insight Molecular Diagnostics Inc. (NASDAQ: IMDX) reported Q2 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $240 thousand versus the consensus estimate of $470.85 thousand.

For earnings history and earnings-related data on Insight Molecular Diagnostics Inc. (IMDX) click here.